| Protein FDR Confidence: Combined | Accession | Description | Exp. q-value: Combined | Sum PEP Score | Coverage [%] | # Peptides | # PSMs | # Unique Peptides | # AAs | MW [kDa] | calc. pI | Abundance Ratio: (DKO) / (WT) | Abundance Ratio: (SKO) / (WT) | Abundance Ratio (log2): (DKO) / (WT) | Abundance Ratio (log2): (SKO) / (WT) | Abundance Ratio P-Value: (DKO) / (WT) | Abundance Ratio P-Value: (SKO) / (WT) | Abundance Ratio Adj. P-Value: (DKO) / (WT) | Abundance Ratio Adj. P-Value: (SKO) / (WT) | Abundances (Grouped): DKO | Abundances (Grouped): SKO | Abundances (Grouped): WT | Abundances (Grouped) CV [%]: DKO | Abundances (Grouped) CV [%]: SKO | Abundances (Grouped) CV [%]: WT | Abundances (Scaled): F1: 127C, Sample, DKO, 1 | Abundances (Scaled): F1: 128C, Sample, DKO, 2 | Abundances (Scaled): F1: 129C, Sample, DKO, 3 | Abundances (Scaled): F1: 130C, Sample, DKO, 4 | Abundances (Scaled): F1: 129N, Sample, SKO, 1 | Abundances (Scaled): F1: 130N, Sample, SKO, 2 | Abundances (Scaled): F1: 131, Sample, SKO, 3 | Abundances (Scaled): F1: 126, Sample, WT, 1 | Abundances (Scaled): F1: 127N, Sample, WT, 2 | Abundances (Scaled): F1: 128N, Sample, WT, 3 | Abundances (Normalized): F1: 127C, Sample, DKO, 1 | Abundances (Normalized): F1: 128C, Sample, DKO, 2 | Abundances (Normalized): F1: 129C, Sample, DKO, 3 | Abundances (Normalized): F1: 130C, Sample, DKO, 4 | Abundances (Normalized): F1: 129N, Sample, SKO, 1 | Abundances (Normalized): F1: 130N, Sample, SKO, 2 | Abundances (Normalized): F1: 131, Sample, SKO, 3 | Abundances (Normalized): F1: 126, Sample, WT, 1 | Abundances (Normalized): F1: 127N, Sample, WT, 2 | Abundances (Normalized): F1: 128N, Sample, WT, 3 | Abundance: F1: 127C, Sample, DKO, 1 | Abundance: F1: 128C, Sample, DKO, 2 | Abundance: F1: 129C, Sample, DKO, 3 | Abundance: F1: 130C, Sample, DKO, 4 | Abundance: F1: 129N, Sample, SKO, 1 | Abundance: F1: 130N, Sample, SKO, 2 | Abundance: F1: 131, Sample, SKO, 3 | Abundance: F1: 126, Sample, WT, 1 | Abundance: F1: 127N, Sample, WT, 2 | Abundance: F1: 128N, Sample, WT, 3 | Abundances Count: F1: 127C, Sample, DKO, 1 | Abundances Count: F1: 128C, Sample, DKO, 2 | Abundances Count: F1: 129C, Sample, DKO, 3 | Abundances Count: F1: 130C, Sample, DKO, 4 | Abundances Count: F1: 129N, Sample, SKO, 1 | Abundances Count: F1: 130N, Sample, SKO, 2 | Abundances Count: F1: 131, Sample, SKO, 3 | Abundances Count: F1: 126, Sample, WT, 1 | Abundances Count: F1: 127N, Sample, WT, 2 | Abundances Count: F1: 128N, Sample, WT, 3 | Biological Process | Cellular Component | Molecular Function | Pfam IDs | Entrez Gene ID | Gene Symbol | Chromosome | Reactome Pathways | Ensembl Gene ID | KEGG Pathways | WikiPathways | # Razor Peptides | Modifications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High | Q91V92 | ATP-citrate synthase OS=Mus musculus OX=10090 GN=Acly PE=1 SV=1 | 0 | 663.315 | 65 | 65 | 379 | 1 | 1091 | 119.7 | 7.44 | 0.754 | 0.946 | -0.41 | -0.08 | 0.974077519 | 0.869516383 | 0.999945597 | 0.996513553 | 83.8 | 105.1 | 111.1 | 60.28 | 27.21 | 33.24 | 17.1 | 114.3 | 70.1 | 125.2 | 155.3 | 91.4 | 112.3 | 130.6 | 65.2 | 118.7 | 12.6 | 84.8 | 52 | 92.9 | 115.2 | 67.8 | 83.3 | 96.9 | 48.3 | 88 | 9.8 | 73 | 46.3 | 80.3 | 107.5 | 55.2 | 83.3 | 88.5 | 42.6 | 81.2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | metabolic process | cytoplasm;cytosol;membrane;mitochondrion | catalytic activity;metal ion binding;nucleotide binding;protein binding | "Pf00285, Pf00549, Pf02629, Pf08442" | 104112 | Acly | 11 | ChREBP activates metabolic gene expression; Neutrophil degranulation; Fatty acyl-CoA biosynthesis | ENSMUSG00000020917.17 | Citrate cycle (TCA cycle); Metabolic pathways | Fatty Acid Biosynthesis | 0 |